Jeffrey Garro
Stock Analyst at Stephens
(0.07)
# 4,450
Out of 4,486 analysts
80
Total ratings
31.3%
Success rate
-22.5%
Average return
Main Sectors:
Stocks Rated by Jeffrey Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPRX OptimizeRx | Rated: Hold | $10 → $7 | $6.26 | +11.91% | 6 | May 13, 2026 | |
| HCAT Health Catalyst | Maintained: Hold | $5 → $1.75 | $2.26 | -22.39% | 4 | May 12, 2026 | |
| CERT Certara | Maintained: Buy | $12 → $9 | $7.17 | +25.52% | 6 | May 12, 2026 | |
| TBRG TruBridge | Maintained: Hold | $18 | $26.23 | -31.38% | 8 | Apr 13, 2026 | |
| PHR Phreesia | Maintained: Buy | $37 → $20 | $10.95 | +82.65% | 3 | Mar 31, 2026 | |
| DH Definitive Healthcare | Maintained: Hold | $5 → $3 | $0.90 | +233.33% | 2 | Feb 27, 2026 | |
| EVH Evolent Health | Maintained: Buy | $7 | $5.48 | +27.74% | 4 | Feb 25, 2026 | |
| SLP Simulations Plus | Maintained: Buy | $28 → $20 | $18.28 | +9.41% | 3 | Jul 15, 2025 | |
| TDOC Teladoc Health | Maintained: Hold | $8 | $9.52 | n/a | 1 | Apr 30, 2025 | |
| PRVA Privia Health Group | Maintained: Buy | $26 → $30 | $27.23 | n/a | 3 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $7 | $4.75 | n/a | 9 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $255 → $250 | $208.23 | n/a | 3 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $280 | $192.30 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $55 | $22.74 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $20 | $24.05 | n/a | 5 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $5 → $3.9 | $11.65 | n/a | 8 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $3 | $0.7259 | n/a | 7 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $141.60 | n/a | 1 | Dec 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | - | n/a | 5 | May 6, 2020 |
OptimizeRx
May 13, 2026
Rated: Hold
Price Target: $10 → $7
Current: $6.26
Upside: +11.91%
Health Catalyst
May 12, 2026
Maintained: Hold
Price Target: $5 → $1.75
Current: $2.26
Upside: -22.39%
Certara
May 12, 2026
Maintained: Buy
Price Target: $12 → $9
Current: $7.17
Upside: +25.52%
TruBridge
Apr 13, 2026
Maintained: Hold
Price Target: $18
Current: $26.23
Upside: -31.38%
Phreesia
Mar 31, 2026
Maintained: Buy
Price Target: $37 → $20
Current: $10.95
Upside: +82.65%
Definitive Healthcare
Feb 27, 2026
Maintained: Hold
Price Target: $5 → $3
Current: $0.90
Upside: +233.33%
Evolent Health
Feb 25, 2026
Maintained: Buy
Price Target: $7
Current: $5.48
Upside: +27.74%
Simulations Plus
Jul 15, 2025
Maintained: Buy
Price Target: $28 → $20
Current: $18.28
Upside: +9.41%
Teladoc Health
Apr 30, 2025
Maintained: Hold
Price Target: $8
Current: $9.52
Upside: n/a
Privia Health Group
Mar 5, 2025
Maintained: Buy
Price Target: $26 → $30
Current: $27.23
Upside: n/a
Jan 31, 2025
Maintained: Hold
Price Target: $13 → $7
Current: $4.75
Upside: n/a
Dec 19, 2024
Initiated Coverage: Buy
Price Target: $255 → $250
Current: $208.23
Upside: n/a
Dec 19, 2024
Initiated Coverage: Buy
Price Target: $280
Current: $192.30
Upside: n/a
Dec 19, 2024
Initiated Coverage: Hold
Price Target: $55
Current: $22.74
Upside: n/a
Aug 5, 2022
Maintained: Buy
Price Target: $15 → $20
Current: $24.05
Upside: n/a
May 11, 2022
Maintained: Sell
Price Target: $5 → $3.9
Current: $11.65
Upside: n/a
May 5, 2022
Maintained: Hold
Price Target: $4 → $3
Current: $0.7259
Upside: n/a
Dec 20, 2021
Maintained: Buy
Price Target: n/a
Current: $141.60
Upside: n/a
May 6, 2020
Reiterated: Hold
Price Target: n/a
Current: -
Upside: n/a